Ascites et causa hepatic cirrhosis
DOI:
https://doi.org/10.18203/2349-3933.ijam20210607Keywords:
Ascites, Hepatic cirrhosis, ComplicationsAbstract
Cirrhosis of the liver is the end result of irreversible hepatocellular injury causing fibrosis and nodular regeneration of the liver. One of the complications of hepatic cirrhosis is ascites. The most common causes of ascites in liver cirrhosis are portal hypertension, hypoalbuminemia and kidney dysfunction which will result in the accumulation of the fluid in the peritoneum. Ascites in cirrhosis is truly important as it is highly associated with mortality, and significantly requires liver transplantation as a therapeutic option. This article reports an SIA woman, 68 years old, diagnosed with ascites e.c hepatic cirrhosis who was treated due to an enlarged abdomen. The patient received diuretic therapy but there were no significant changes. The patient also received an ascitic fluid puncture procedure. Cirrhosis of the liver is a condition where the extracellular matrix or scar tissue accumulates as a response to acute or chronic liver injury. Ascites is the most likely complication occurred in cirrhosis patients. The occurrence of ascites in cirrhosis is very important which is correlated to the patient’s mortality. Adequate ascites therapy will levitate the quality of life for cirrhosis patients and prevent complications.
References
Nurdjanah S, Hati S. Buku ajar ilmu penyakit dalam jilid 2. Edisi ke-6. Jakarta: Balai Penerbit FKUI. 2014;1978.
Stasi C, Silvestri C, Voller F, Cipriani F. Epidemiology of liver cirrhosis. J Clin Exper Hep. 2015;5:272.
D’amico G, Morabito A, D’amico M, Malizia G, Rebora P, Valsecchi MG. Clinical states of cirrhosis and. Competing risks. J Hep. 2017.
Hsu S, Huang H. Management of ascites in patients with liver cirrhosis : recent evidence and controversies. Journal of Chinese Med. 2013;123-30.
Caesario K, Choure A, Carey W. Cirrhotic ascites. Cleveland Clin. Med. Ed. 2017.
Adebayo D, Neong S, Wong F. Refractory ascites in liver cirrhosis. Am J Gastroenterol. 2018.
Pose E, Cardenas A. Translating our current understanding of ascites management into new therapies for patients with cirrhosis and fluid retention. Dig Dis. 2017;35:402-10.
Amer M, Elsiesy H. Ascites: causes, diagnosis, and treatment. Intech. 2017.
Tan HK, James PD, Wong F. Albumin may prevent the morbidity of paracentesis-induced circulatory dysfunction in cirrhosis and refractory ascites: a pilot study. Dig Dis Sci. 2016;61:3084-92.
Pendersen J, Bendtsen F, Moller S. Management of cirrhotic ascites. Ther Adv Chronic Dis. 2015;6(3):124-37.
Maghfirah D, Abubakar A, Yusuf F. Penatalaksanaan asites pada sirosis hepatis. J Ked Med. 2018.
Aithal G, Palaniyappan N, China L, Harmala S, Macken L, Ryan J, et al. Guidelines on the management of ascites in cirrhosis. Gut Journal. 2020;70:9-29.
Morando F, Rosi S, Gola E. Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. Liver Int. 2015;35:1508-15.
Bernardi M, Caraceni P, Navickis RJ. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large volume paracentesis?. Expert Rev Gastroenterol Hepatol. 2017;11:191-2.
